Skip to content

Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi

Home Assessment and Initiation of ART: a Cluster-randomised Trial in Blantyre, Malawi

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01414413
Acronym
CONDA-YAPA
Enrollment
16660
Registered
2011-08-11
Start date
2012-01-31
Completion date
2013-04-30
Last updated
2014-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, AIDS, Antiretroviral therapy, Community-based study, Cluster-randomised trial, HIV testing, Africa

Brief summary

Despite increasing availability of antiretroviral therapy (ART) for HIV in high prevalence countries, the majority of people with HIV infection still initiate treatment at an advanced stage of disease. This leads to a high risk of death soon after HIV diagnosis. Prompt HIV diagnosis is, therefore, necessary for both individual and public health benefit and is being strongly promoted as international and national policy in Malawi. However timely HIV diagnosis may not in itself be sufficient to ensure ART initiation: this is reflected by the relatively high proportion of individuals who defer treatment-seeking for months or years following diagnosis of HIV. Here the researchers investigate the extent to which home assessment and initiation of ART adds to the effectiveness of a home-based HIV testing and counseling strategy, using entry to, adherence with, and retention in HIV care as the outcome of interest.

Interventions

OTHERHome assessment and initiation of ART

Home-based ART eligibility assessment (WHO staging, CD4 count measurement and educational treatment preparation) and initiation.

OTHERClinic-based ART assessment and initiation

Participants who meet eligibility criteria and reside in a cluster that has been allocated to the control arm of this study will receive supported access to ART care through the primary care system for confirmation of HIV status and entry into HIV following disclosure to the resident community counsellor.

Sponsors

Kamuzu University of Health Sciences
CollaboratorOTHER
London School of Hygiene and Tropical Medicine
CollaboratorOTHER
Ministry of Health and Population, Malawi
CollaboratorOTHER_GOV
Liverpool School of Tropical Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Usual resident of an eligible cluster * Has had a positive HIV test (regardless of source) and requests facilitated access to HIV care from the resident community counsellor * Confirmatory HIV test is positive * No previous ART treatment, or less than one month's treatment in the past (including PMTCT interventions) and not currently receiving HIV care * No contraindications to receiving ART (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO) * No acute danger signs requiring hospital referral * Aged 18 years or older * Written or witnessed informed consent to participate in the study

Exclusion criteria

* Not a usual resident of an eligible cluster * No previous HIV test, or HIV infection not confirmed by home-based ART nurse * Already receiving ART, or has had more than 1 month's treatment in the past * Known contraindication to firstline ART (known hypersensitivity, renal failure, chronic liver disease) * Acute danger sign present (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO) * Age younger than 18 years * Not willing to accept home-based ART initiation * Suspected or confirmed TB disease will not be an

Design outcomes

Primary

MeasureTime frameDescription
ART InitiationFirst six months following introduction of home-based HIV testingComparison between study arms of the proportion of all resident adults (per capita, and irrespective of HIV status or participation in home-based HIV testing intervention) who initiate ART during the first 6 months of the home-based HIV-testing intervention.

Secondary

MeasureTime frameDescription
Uptake of Home-based HIV TestingThe first 6-months following home assessment and initiation of ART being made availableComparison between study arms of the proportion of all resident adults who request HIV testing (either as standard HTC or as supervised HIV self-testing) from the resident community counsellor during the first year of the study.
Reporting of HIV-positive ResultsThe first 6-months following availability of home-based HIV testingComparison of the proportion of all cluster adults confiding HIV-positive results to the resident community counsellor between study arms during the 1-year study period
Loss to RetentionThe first 6-months following availability of home-based HIV testingComparison between study arms of the proportion of participants who initiate ART during the first 6-months of the HIV-testing intervention who are lost to retention within 6 months after initiating ART 6-months
Adherence to ARTFirst 6-months following availability of home-based HIV testingComparison between study arms of the proportion of HIV-positive participants who are adherent to ART during the 1-year study period
Adult MortalityThe first 6-months following availability of home-based HIV testingComparison between study arms of non-traumatic and HIV-related adult (15-49) mortality rates during the first 6 months of the HIV-testing intervention

Countries

Malawi

Participant flow

Participants by arm

ArmCount
Home Assessment and Initiation of ART
8194 adults resident in 3213 households
8,194
Clinic-based ART Assessment and Initiation
8466 adults resident in 3397 households
8,466
Total16,660

Baseline characteristics

CharacteristicHome Assessment and Initiation of ARTClinic-based ART Assessment and InitiationTotal
Age, Continuous30.4 years
STANDARD_DEVIATION 11.8
30.2 years
STANDARD_DEVIATION 11.4
30.3 years
STANDARD_DEVIATION 11.6
Sex: Female, Male
Female
3942 Participants4067 Participants8009 Participants
Sex: Female, Male
Male
4252 Participants4399 Participants8651 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 8,1940 / 8,466
serious
Total, serious adverse events
0 / 8,1940 / 8,466

Outcome results

Primary

ART Initiation

Comparison between study arms of the proportion of all resident adults (per capita, and irrespective of HIV status or participation in home-based HIV testing intervention) who initiate ART during the first 6 months of the home-based HIV-testing intervention.

Time frame: First six months following introduction of home-based HIV testing

ArmMeasureValue (NUMBER)
Home Assessment and Initiation of ARTART Initiation181 participants
Clinic-based ART Assessment and InitiationART Initiation63 participants
Secondary

Adherence to ART

Comparison between study arms of the proportion of HIV-positive participants who are adherent to ART during the 1-year study period

Time frame: First 6-months following availability of home-based HIV testing

Secondary

Adult Mortality

Comparison between study arms of non-traumatic and HIV-related adult (15-49) mortality rates during the first 6 months of the HIV-testing intervention

Time frame: The first 6-months following availability of home-based HIV testing

Secondary

Loss to Retention

Comparison between study arms of the proportion of participants who initiate ART during the first 6-months of the HIV-testing intervention who are lost to retention within 6 months after initiating ART 6-months

Time frame: The first 6-months following availability of home-based HIV testing

ArmMeasureValue (NUMBER)
Home Assessment and Initiation of ARTLoss to Retention52 participants
Clinic-based ART Assessment and InitiationLoss to Retention15 participants
Secondary

Reporting of HIV-positive Results

Comparison of the proportion of all cluster adults confiding HIV-positive results to the resident community counsellor between study arms during the 1-year study period

Time frame: The first 6-months following availability of home-based HIV testing

ArmMeasureValue (NUMBER)
Home Assessment and Initiation of ARTReporting of HIV-positive Results490 participants
Clinic-based ART Assessment and InitiationReporting of HIV-positive Results278 participants
Secondary

Uptake of Home-based HIV Testing

Comparison between study arms of the proportion of all resident adults who request HIV testing (either as standard HTC or as supervised HIV self-testing) from the resident community counsellor during the first year of the study.

Time frame: The first 6-months following home assessment and initiation of ART being made available

ArmMeasureValue (NUMBER)
Home Assessment and Initiation of ARTUptake of Home-based HIV Testing5287 participants
Clinic-based ART Assessment and InitiationUptake of Home-based HIV Testing4433 participants

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026